Evidence map›Paper›PMID 15256499›Full record

ArticleGenes & development2004

A signaling mucin at the head of the Cdc42- and MAPK-dependent filamentous growth pathway in yeast.

Paul J Cullen, Walid Sabbagh, Ellie Graham, Molly M Irick, Erin K van Olden, Cassandra Neal, Jeffrey Delrow, Lee Bardwell, George F Sprague

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Genes & development, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 213 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Screening and In Silico Analyses of the YeastFoods (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Paul J CullenInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229, USA.
Walid Sabbagh
Ellie Graham
Molly M Irick
Erin K van Olden
Cassandra Neal
Jeffrey Delrow
Lee Bardwell
George F Sprague
Fred Hutch Cancer Center · USUniversity of California, Irvine · USUniversity of Oregon · US

Funding

GENETIC REGULATION OF YEAST CELL TYPER01GM030027 · NIGMS · UNIVERSITY OF OREGON · PI SPRAGUE, GEORGE F. · 1985 to 2008
$3.0M
MAP KINASE CASCADE SIGNAL TRANSMISSION AND SPECIFICITYR01GM060366 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARDWELL, LEE S · 2000 to 2008
$2.2M
NIGMS NIH HHS GM-30027NIGMS NIH HHS GM-60366NIGMS NIH HHS R01 GM030027NIGMS NIH HHS R01 GM060366
6 · The paper itself

Abstract

Signaling molecules such as Cdc42 and mitogen-activated protein kinases (MAPKs) can function in multiple pathways in the same cell. Here, we propose one mechanism by which such factors may be directed to function in a particular pathway such that a specific response is elicited. Using genomic approaches, we identify a new component of the Cdc42- and MAPK-dependent signaling pathway that regulates filamentous growth (FG) in yeast. This factor, called Msb2, is a FG-pathway-specific factor that promotes differential activation of the MAPK for the FG pathway, Kss1. Msb2 is localized to polarized sites on the cell surface and interacts with Cdc42 and with the osmosensor for the high osmolarity glycerol response (HOG) pathway, Sho1. Msb2 is glycosylated and is a member of the mucin family, proteins that in mammalian cells promote disease resistance and contribute to metastasis in cancer cells. Remarkably, loss of the mucin domain of Msb2 causes hyperactivity of the FG pathway, demonstrating an inhibitory role for mucin domains in MAPK pathway activation. Taken together, our data suggest that Msb2 is a signaling mucin that interacts with general components, such as Cdc42 and Sho1, to promote their function in the FG pathway.

Indexed as

Amino Acid SequenceBlotting, Westerncdc42 GTP-Binding ProteinEnzyme ActivationGTPase-Activating ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsMicroscopy, FluorescenceMolecular Sequence DataOligonucleotide Array Sequence AnalysisPrecipitin TestsProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionTwo-Hybrid System Techniquescdc42 GTP-Binding ProteinGTPase-Activating ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsMSB2 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSHO1 protein, S cerevisiae

Identifiers

PMID15256499
PMCPMC478191
OpenAlexW2102224568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.